Are all Type I human interferons equivalent?

被引:83
作者
Foster, GR
Finter, NB
机构
[1] St Marys Hosp, Liver Unit, Imperial Coll Sch Med, London W2 1PG, England
[2] Tideswell, Sevenoaks, Kent, England
关键词
immunomodulation; interferon; subtypes;
D O I
10.1046/j.1365-2893.1998.00103.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Type I interferons are a family of closely related cytokines that have antiviral and immunostimulatory properties. There has been prolonged debate regarding the different interferon-alpha subtypes: with some authorities suggest that the different interferons have essentially similar properties but others argue that there are significant differences between them. Recent work has shown that the various interferon-alpha subtypes can interact with the interferon receptor components in different ways and can activate a number of different signalling pathways. Recent studies on the immunomodulatory properties of the Type I interferons indicate that there are profound differences between the subtypes. The clinical significance of all these differences remains to be determined.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 61 条
  • [1] NOMENCLATURE OF THE HUMAN INTERFERON PROTEINS
    ALLEN, G
    DIAZ, MO
    FINTER, NB
    ADOLF, GR
    DOLY, J
    LUNDGREN, E
    PESTKA, S
    ROBERTS, RM
    TESTA, D
    WIETZERBIN, J
    [J]. JOURNAL OF INTERFERON RESEARCH, 1994, 14 (04): : 223 - 226
  • [2] NEUTRALIZING ANTIBODIES TO INTERFERON-ALPHA - RELATIVE FREQUENCY IN PATIENTS TREATED WITH DIFFERENT INTERFERON PREPARATIONS
    ANTONELLI, G
    CURRENTI, M
    TURRIZIANI, O
    DIANZANI, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) : 882 - 885
  • [3] CLINICAL-SIGNIFICANCE OF RECOMBINANT INTERFERON-ALPHA(2) NEUTRALIZING ANTIBODIES IN HEPATITIS PATIENTS
    ANTONELLI, G
    GIANNELLI, G
    PISTELLO, M
    MAGGI, F
    VATTERONI, L
    CURRENTI, M
    DELVECCHIO, S
    ROFFI, L
    PASTORE, G
    DIANZANI, F
    [J]. JOURNAL OF INTERFERON RESEARCH, 1994, 14 (04): : 211 - 213
  • [4] ANTONELLI G, 1993, ARCH VIROL, P271
  • [5] BEASLEY RP, 1981, LANCET, V2, P1129
  • [6] ANTIBODIES DEVELOPING AGAINST A SINGLE RECOMBINANT INTERFERON PROTEIN MAY NEUTRALIZE MANY OTHER INTERFERON-ALPHA SUBTYPES
    BRAND, CM
    LEADBEATER, L
    BELLATI, G
    MAROTTA, F
    IDEO, G
    [J]. JOURNAL OF INTERFERON RESEARCH, 1993, 13 (02): : 121 - 125
  • [7] REQUIREMENT FOR MAP KINASE (ERK2) ACTIVITY IN INTERFERON-ALPHA-STIMULATED AND INTERFERON-BETA-STIMULATED GENE-EXPRESSION THROUGH STAT PROTEINS
    DAVID, M
    PETRICOIN, E
    BENJAMIN, C
    PINE, R
    WEBER, MJ
    LARNER, AC
    [J]. SCIENCE, 1995, 269 (5231) : 1721 - 1723
  • [8] Comparative effects of interferon-consensus 1, interferon-alpha(2a), and interferon-beta(1b), on HLA expression and lymphoproliferation: A preclinical model for treatment of multiple sclerosis
    DhibJalbut, S
    Jiang, H
    Xia, QA
    Blatt, L
    Johnson, KP
    Hilt, D
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (03) : 195 - 200
  • [9] Evinger M, 1980, Ann N Y Acad Sci, V350, P399, DOI 10.1111/j.1749-6632.1980.tb20641.x
  • [10] Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C
    Fattovich, G
    Giustina, G
    Degos, F
    Diodati, G
    Tremolada, F
    Nevens, F
    Almasio, P
    Solinas, A
    Brouwer, JT
    Thomas, H
    Realdi, G
    Corrocher, R
    Schalm, SW
    Bhalla, A
    Casarin, C
    Bonetti, P
    Basho, J
    Fuschi, P
    Tocco, A
    Mura, D
    [J]. JOURNAL OF HEPATOLOGY, 1997, 27 (01) : 201 - 205